Selektivní imunosupresiva – Ustekinumab III.
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 20485373 | 13. 10. 2022 | Janssen-Cilag s.r.o. | 32 825 100,00 | 29 841 000,00 | 32 825 100,00 | 29 841 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 455_Písemná zpráva.pdf | Písemná zpráva zadavatele | 14. 11. 2022 10:25 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| Janssen-Cilag s.r.o. | Praha | 29 535 864,00 | CZK |
Price Actually Paid in Each Year of Performance
| 20485373 | 2023 | 12 633 226,00 | 11 484 750,95 |
| 20485373 | 2022 | 1 258 203,07 | 1 143 820,97 |